HTA72 Survival Extrapolation for Immuno-Oncology Drugs: Pessimism or Optimism? a Targeted Literature Review and a Validation-Based Case Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1204
https://www.valueinhealthjournal.com/article/S1098-3015(22)01405-X/fulltext
Title :
HTA72 Survival Extrapolation for Immuno-Oncology Drugs: Pessimism or Optimism? a Targeted Literature Review and a Validation-Based Case Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01405-X&doi=10.1016/j.jval.2022.04.1204
First page :
Section Title :
Open access? :
No
Section Order :
11078